BSAC publishes two leading peer-reviewed journals, providing a bedrock of robust research and evidence for the global infection community. From the established Journal of Antimicrobial Chemotherapy (JAC) to open-access JAC-Antimicrobial Resistance (JAC-AMR), our journals inform practice, policy and innovation worldwide

The Journal of Antimicrobial Chemotherapy (JAC) is a leading international journal which publishes research on the laboratory aspects and clinical use of antimicrobials, including antibacterial, antiviral, antifungal and antiprotozoal agents

Published monthly, it reaches a global readership across academia, industry and healthcare, including those involved in formulary decisions. Each issue features original research, reviews and Editor’s Choice papers, which are open access to all

Access JAC    

JAC-Antimicrobial Resistance (JAC-AMR) is BSAC’s open access journal dedicated to advancing knowledge and research on antimicrobial resistance. It publishes clinically relevant opinions, reviews and original research from a wide range of disciplines addressing this global health challenge.

The journal also hosts an online repository of educational resources that support learning on antimicrobial stewardship, antimicrobial resistance and behaviour change for a worldwide audience.

Access JAC-AMR